Riskpilot← Back to searchSign inGet full accessUNIVERSAL HELSEPRODUKTER AS
ASActiveOrg 984608950Mosseveien 14B, 0193 OsloWholesale of other food · NACE 4638Est. 20025 employees
Revenue 2024
NOK 1,6M
-20% vs 2023
EBITDA margin
-17.1%
-156% vs 2023
Equity ratio
84.9%
Financial strength
Net profit 2024
NOK -295K
-168% vs 2023
| Revenue | NOK 1,6M | -20% |
| EBITDA | NOK -280K | -156% |
| Net profit | NOK -295K | -168% |
| Total assets | NOK 942K | -26% |
| Equity | NOK 800K | -27% |
| Employees | 5 | — |
Legal name
UNIVERSAL HELSEPRODUKTER AS
Org number
984608950
Legal form
Aksjeselskap
NACE code
4638 · Wholesale of other food
Founded
1. juli 2002
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Innkjøp og salg av helseprodukter. Helost og alt i den forbindelse
Address
Mosseveien 14B, 0193 Oslo
Phone
+4722692412
Email
daniel@universalhelseprodukter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 887 | 2 370 | 2 323 | 2 054 | 1 635 |
| Staff expenses | −175 | −194 | −132 | −38 | −420 |
| EBITDA | 122 | 223 | 296 | 504 | −280 |
| Depreciation & amort. | −48 | −45 | −44 | −22 | −0 |
| EBIT | 74 | 177 | 252 | 482 | −280 |
| Net financials | −34 | −32 | −33 | −19 | −14 |
| Profit before tax | 40 | 145 | 218 | 463 | −295 |
| Tax | −0 | −0 | −0 | 28 | −0 |
| Net profit | 40 | 145 | 218 | 435 | −295 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 955 | 846 | 898 | 1 276 | 942 |
| Equity | 297 | 442 | 660 | 1 095 | 800 |
| Long-term debt | 538 | 254 | 79 | 5 | 0 |
| Short-term debt | 120 | 151 | 159 | 177 | 142 |
| Total debt | 659 | 404 | 239 | 181 | 142 |
EBITDA margin
-17.1%
This company
15.8%
Market median
-208% vs market
20202024
Equity ratio
84.9%
This company
38.2%
Market median
+122% vs market
20202024
Return on equity
-36.8%
This company
18.4%
Market median
-300% vs market
20202024
Net profit margin
-18.0%
This company
8.1%
Market median
-322% vs market
20202024
Asset turnover
1.74×
This company
1.12×
Market median
+55% vs market
20202024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AE Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
IF Chief Executive Officer | Chief Executive Officer | 2024 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Chairman | 2024 – 2025 | |
| Chairman | 2017 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of UNIVERSAL HELSEPRODUKTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Idun Fjellheim | Chief Executive Officer | 0 companies |
| Amiram Eini | Chief Executive Officer | 0 companies |
| Ilan Eini | Chairman | 0 companies |
| Daniel Eini | Chairman | 0 companies |